Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc.

This study tested whether a new drug called ciraparantag could safely and effectively reverse the effects of the blood thinner rivaroxaban. Healthy volunteers aged 50-75 took rivaroxaban for three days, then received either ciraparantag or a placebo to see how quickly their blood…

This study tested a new drug called ciraparantag to see if it could quickly reverse the effects of a common blood thinner (apixaban). The goal was to help control dangerous bleeding in emergencies. Healthy volunteers took the blood thinner and then received either the reversal dr…